INTRODUCTION
PAKs (p21-activated kinases) are effectors of RhoGTPases, including Cdc42, Rac1 and RhoA, and play essential roles in controlling many cellular functions such as cell survival and motility [1, 2] . PAK4 together with PAK5 and PAK6 belong to group II of PAKs [2] . Of these, PAK4 and PAK5 are localized at the leading edge of migrating cells, whereas PAK6 is mainly localized to the nucleus [1, 3] . At the leading edge, PAK4 is a member of a multiprotein complex comprising LIMK (Lin-11/Isl-1/Mec-3 kinase), SSH1L (Slingshot 1L) and 14-3-3 proteins [4] . Activation of LIMK by PAK4 mediates phosphorylation and inactivation of cofilin, and this is part of the 'cofilin cycle' that facilitates actin reorganization processes required for directed cell migration [4] [5] [6] [7] . In many cancers, PAK4 was shown to be overexpressed or mutated, and its inhibition by pharmacological means was suggested to target cancer metastases [2, 8] .
PAK4 requires activation loop phosphorylation at Ser 474 for its activity [9, 10] . Phosphorylation of this site can be mediated by autophosphorylation and by PKD1 (protein kinase D1) [10, 11] . However, Ser 474 -phosphorylated PAK4 only acquires full activity upon binding to RhoGTPases and release of its AID (autoinhibitory domain) [12] . The mechanisms by which PAK4 is directed to the leading edge, however, are unknown.
PKD1 is down-regulated in expression or activity in invasive breast, prostate and gastric cancer [13] [14] [15] . In response to active RhoA, PKD1 negatively regulates cofilin activity at the leading edge by phosphorylating key enzymes in both of its regulatory pathways. PKD1 phosphorylates PAK4 at Ser 474 mediating its activation and downstream signalling to LIMK [11] . It also phosphorylates the cofilin phosphatase SSH1L at multiple sites mediating its inactivation [16] [17] [18] . The net effect of such signalling is a shift of the cofilin pool at the leading edge to the phosphorylated inactive state, resulting in inhibition of barbed end formation and directed cell migration [19] .
In the present study, we identify a previously undescribed mechanism that is required to target PAK4 to the leading edge. We show that PKD1-mediated phosphorylation of PAK4 at Ser 99 generates a binding site for 14-3-3 proteins. Ser 99 phosphorylation and 14-3-3 binding is necessary for localization of PAK4 to the leading edge, and mutation of this residue to alanine leads to its retention in the cytosol.
MATERIALS AND METHODS

Cell lines, antibodies and reagents
All cell lines were obtained from the A.T.C.C. (Manassas, VA, U.S.A.). HEK (human embryonic kidney)-293T and HeLa cells were maintained in DMEM (Dulbecco's modified Eagle's medium) with 10 % (v/v) FBS. Anti-PKD1 and anti-14-3-3 antibodies were from Santa Cruz Biotechnology, anti-PKD3 antibody was from Bethyl Laboratories, anti-HA (haemagglutinin), anti-FLAG (M2) and anti-β-actin antibodies were from Sigma-Aldrich, anti-PKD2 and anti-His antibodies were from Millipore, and anti-pMOTIF (PKD substrate antibody), anti-LIMK, anti-PAK4, anti-pSer 474 -PAK4, anti-cofilin and antipSer 3 -cofilin antibodies were from Cell Signaling Technology. Secondary HRP (horseradish peroxidase)-linked antibodies were from Millipore. Secondary antibodies for immunofluorescence [Alexa Fluor ® 568-conjugated F(ab ) 2 fragment of goat anti-(mouse IgG) or Alexa Fluor ® -conjugated 546 F(ab ) 2 fragment of goat anti-rabbit] were from Invitrogen. HeLaMONSTER ® (Mirus) was used for transient transfection of HeLa cells, and TransIT ® -293 (Mirus) was used for transient transfection of HEK-293T cells. The PKD inhibitor CID755673 was from Tocris Bioscience and the PAK4 inhibitor was from MedKoo Biosciences. Purified recombinant PKD1 was from Millipore, and PKD2 and PKD3 were both from Enzo Life Sciences.
Abbreviations used: F-actin, filamentous actin; G-actin, globular actin; HA, haemagglutinin; HEK, human embryonic kidney; LIMK, Lin-11/Isl-1/Mec-3 kinase; PAK, p21-activated kinase; PAK4.KM, kinase-dead PAK4 (PAK4.K350M); PKD, protein kinase D; PKD1.CA, constitutively active PKD1 (PKD1.S738E.S742E); PKD1.KW, kinase-dead PKD1 (PKD1.K612W); PKD2.KW, kinase-dead PKD2 (PKD2.K580W); SSH1L, Slingshot 1L; TBST, TBS with 0.2 % Tween 20.
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DNA constructs
The expression plasmids for HA-tagged constitutively active PKD1 (PKD1.CA, PKD1-S738E.S742E mutation) and HAtagged kinase-inactive PKD1 (PKD1.KW, PKD1.K612W mutation) were described previously [20] . The expression plasmid for FLAG-tagged kinase-inactive PKD2 (PKD2.KW, PKD2.K580W mutation), was generated by site-directed mutagenesis using a previously described plasmid as template [21] and the primer pair 5 -GGCCGGGACGTGGCAG-TTTGGGTCATTGACAAACTGCGC-3 and 5 -GCGCAG-TTTGTCAATGACCCAAACTGCCACGTCCCGGCC-3 . The expression plasmids for FLAG-tagged or GST-tagged (GSTfusion proteins) human wild-type, K350M-and S474A-mutated PAK4 were described previously [11] . To obtain S99A-mutated PAK4, site-directed mutagenesis was carried out using the QuikChange ® kit (Stratagene), wild-type, K350M-and/or S474A-mutated PAK4 expression constructs as template, and 5 -GTGACACGCTCCAACGCCCTGCGGAGAGACAGC-3 and 5 -GCTGTCTCTCCGCAGGGCGTTGGAGCGTGTCAC-3 as primers.
In vitro kinase assays
Kinase assays with GST-fusion proteins were carried out by adding 250 ng of active purified PKD enzyme to 2 μg of purified GST or GST-fusion protein in a volume of 40 μl of kinase buffer (50 mM Tris/HCl, pH 7.4, 10 mM MgCl 2 and 2 mM DTT) supplemented with 100 μM ATP (non-radioactive assay) or 100 μM ATP containing 10 μCi of [γ -32 P]ATP in kinase buffer (radioactive assay). The kinase reaction [30 min at room temperature (22 • C)] was stopped by adding 2× Laemmli buffer.
Immunoprecipitation, PAGE, far-Western blot and immunoblotting
Cells were washed twice with 4
• C PBS (140 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 and 1.5 mM KH 2 PO 4 , pH 7.2) and then lysed using lysis buffer I (50 mM Tris/HCl, pH 7.4, 1 % Triton X-100, 150 mM NaCl and 5 mM EDTA, pH 7.4) plus protease inhibitor cocktail (Sigma-Aldrich). After vortex-mixing and incubating for 30 min on ice, lysates were centrifuged at 16 000 g for 15 min at 4
• C. To obtain the actin fraction, pellets were resolved in lysis buffer II (50 mM Tris/HCl, pH 7.6, 150 mM NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 1% Nonidet P40 and 10 % glycerol) plus protease inhibitor cocktail and boiled (details described in [17] ). For all other experiments, either the supernatant was collected and subjected directly to SDS/PAGE (Western blotting) or proteins of interest were immunoprecipitated by incubating for 1 h at 4
• C with a specific antibody (2 μg) followed by another 30 min incubation with Protein G-Sepharose (GE Healthcare). After washing the immune complexes three times with TBS (50 mM Tris/HCl, pH 7.4, and 150 mM NaCl), 20 μl of TBS and 20 μl of 2× Laemmli buffer were added, and the samples were subjected to SDS/PAGE. Proteins were transferred on to nitrocellulose membranes and visualized by immunostaining or subjected to far-Western blotting. • C. Membranes then were washed three times briefly with TBST and 14-3-3ζ binding to proteins was visualized by immunostaining with an anti-His antibody.
Immunofluorescence
Cells were either seeded and transfected in eight-well ibiTreat μ-Slides (ibidi, Integrated BioDiagnostics), or grown in 6-cmdiameter plates, transfected as indicated and reseeded on to coverslips in a 24-well plate at a density of 2×10 4 cells/well. The following day, cells were washed with PBS and then fixed with 4 % (w/v) paraformaldehyde for 15 min at 37
• C. Following two washes with PBS, cells were permeabilized with 0.1 % Triton X-100 for 10 min at room temperature and blocked with 3 % (w/v) BSA and 0.05 % Tween 20 in PBS (blocking solution) for 30 min at room temperature. The samples were then incubated with primary antibody (anti-FLAG diluted 1:4000 in blocking solution) overnight at 4
• C. Samples were washed five times with PBS and incubated with secondary antibody [Alexa Fluor ® 568 F(ab ) 2 fragment of goat anti-(mouse IgG) or Alexa Fluor ® 488 F(ab ) 2 fragment of goat anti-rabbit] at a dilution of 1:1600 in blocking solution for 2 h at room temperature. F-actin (filamentous actin) and nuclei were stained together with secondary antibodies by incubating with phalloidin (Alexa Fluor ® 633-phalloidin; Invitrogen) and DAPI (Sigma-Aldrich) respectively in blocking solution. Following three washes with PBS, the coverslips were mounted on to slides using Fluoromount-G (SouthernBiotech) and examined using a IX81 DSU spinningdisc confocal microscope from Olympus with a ×40 objective. Images were processed using ImageJ (NIH).
Analysis of free actin filament barbed ends
Cells were transfected and reseeded on eight-well ibiTreat μ-Slides and serum-starved for 16 h. The medium was then removed, cells were washed with pre-warmed PBS, permeabilized and labelled with 0.4 μM Alexa Fluor ® 594-conjugated actin in permeabilization buffer (20 mM Hepes, 138 mM KCl, 4 mM MgCl 2 , 3 mM EGTA, 0.2 mg/ml saponin and 1 % BSA) plus 1 mM ATP for 30 s at 37
• C. The cells were fixed with 4 % (w/v) paraformaldehyde in PBS at room temperature for 10 min. Samples were examined using the IX81 DSU spinning-disc confocal microscope.
Impedance-based real-time cell migration and proliferation assays
Cells were transfected as indicated and, after 24 h, were seeded on Transwell CIM-plate 16 (motility assays) or Eplates (proliferation assays) from Roche. For proliferation assays, after attachment of cells on the E-plate, impedance was continuously monitored in real-time over a period of 16 h using the xCELLigence RTCA DP instrument (Roche). For migration assays, after attachment of cells, cell migration towards NIH 3T3-conditioned medium was continuously monitored in realtime (over 16 h) using the xCELLigence RTCA DP instrument (Roche).
Transwell assays
Cells were transfected and, after 24 h, were suspended in 0.1 % BSA in serum-free medium and seeded into Transwells containing a polycarbonate membrane with pores of 8 μm (Corning). After allowing cells to migrate towards NIH 3T3-conditioned medium (for 16 h), the cells on top of the Transwell were removed. The remaining cells were fixed with 3.7 % (w/v) formaldehyde for 30 min at room temperature, stained with β-gal solution [40 μM K 3 Fe(CN) 6 , 40 μM K 4 Fe(CN) 6 
Statistical analysis
Results are means + − S.D. P values were acquired with Student's t test using GraphPad Prism software, and P < 0.05 is considered statistically significant.
RESULTS
PKD1 phosphorylates PAK4 at Ser
99
PAK4 can autophosphorylate at Ser 474 , a key residue in the activation loop of the kinase domain that contributes to activity [10] . Using a kinase-dead PAK4 (PAK4.KM, PAK4.K350M), PKD1 also was shown to directly phosphorylate this residue in vitro and in vivo [11] . In vitro kinase assays with PKD1 and GST-tagged purified kinase-dead PAK4 additionally mutated at Ser 474 (GST-PAK4.K350M.S474A mutant) expectedly led to a loss of PAK4 phosphorylation at Ser 474 . However, probing PKD-phosphorylated GST-PAK4.K350M.S474A with the pMOTIF antibody that is designed to recognize the phosphorylated PKD consensus motif [22, 23] still picked up a GST-PAK4.K350M.S474A mutant, indicating additional PKD1 phosphorylation sites in PAK4 ( Figure 1A) .
Analysis of the amino acid sequence of PAK4 indicated only one additional PKD phosphorylation consensus motif (VTRSNS 99 ) that is conserved between species and is also present in PAK5, but not in PAK6 ( Figure 1B ). Moreover, Ser 99 phosphorylation of PAK4 has been previously detected by MS [24] and was reported in phosphorylation databases such as Phosphosite (http://www.phosphosite.org). We therefore tested whether PKD1 can phosphorylate PAK4 at Ser 99 . We performed in vitro kinase assays with a series of bacterially expressed GST-PAK4 fusion proteins encompassing kinase-dead PAK4 (K350M mutation) combined with S474A or S99A, or both, mutations ( Figure 1C ). In vitro kinase assays using radioactive ATP as well as non-radiolabelled kinase assays and probing with antipSer 474 -PAK4 and anti-pMOTIF antibodies suggested that PKD1 indeed can phosphorylate PAK4 at both Ser 99 and Ser 474 . For example, a kinase-dead and S474A-mutated PAK4 was still phosphorylated by PKD1 (77 % of control), whereas an S99A mutant was phosphorylated significantly less (33 % of control). Only mutation of both sites fully diminished PKD1-mediated phosphorylation. Probing non-radiolabelled kinase assays with anti-pMOTIF indicated that this antibody primarily recognizes PAK4 phosphorylated at Ser 99 . Moreover, probing with antipSer 474 -PAK4 suggested that the phosphorylation at Ser 99 may prime for PKD1-mediated phosphorylation at Ser 474 in vitro ( Figure 1C , compare PKD1-phosphorylated GST-PAK4.K350M with PKD1-phosphorylated GST-PAK4.K350M.S99A, α-pS474-PAK4 blot). Of the two other PKD family members, only PKD2 is a Ser 99 kinase, whereas PKD2 and PKD3 are Ser We then tested whether active PKD1 mediates phosphorylation of PAK4 at Ser 99 in cells. We therefore expressed a kinasedead PAK4 mutant (PAK4.KM) or a kinase-dead double mutant (PAK4.KM.S474A) in combination with PKD1.CA or PKD1.KW. Additionally, all cells were treated with the PAK4 inhibitor PF-3758309 [25] to block phosphorylations by endogenous PAK4. We found that active PKD1 phosphorylated PAK4.KM as well as PAK4.KM.S474A, but to a lesser extent. PKD1.KW blocked both phosphorylations. This indicates that PKD1 can contribute to the phosphorylation of both residues in cells ( Figure 1D ).
Next Figure 1E ). This may be explained by previous studies demonstrating a high autophosphorylation activity of PAK4 towards this residue [10] . We therefore applied the PAK4 inhibitor PF-3758309 to dampen PAK4 autophosphorylation. Under such conditions, PKD1.CA induced PAK4 phosphorylation at Ser 474 in wild-type PAK4, but significantly less in the PAK4.S99A mutant ( Figure 1F ). In summary, our results indicate that Ser 99 phosphorylation, to some extent, can prime for PKD1-mediated Ser 474 phosphorylation, but is not necessary for PAK4 autophosphorylation at this serine residue.
Ser 99 is necessary for the localization of PAK4 to the leading edge
The group II PAKs PAK4 and PAK5 which contain the Ser 99 phosphorylation motif locate to the leading edge, whereas PAK6 which does not contain this motif is a nuclear protein (Supplementary Figure S2 at http://www.biochemj.org/bj/ 455/bj4550251add.htm). This prompted us to test whether the phosphorylation of this residue by PKD1 can affect the cellular localization of PAK4. In HeLa cells, endogenous and overexpressed PKD1 is localized to the leading edge where it co-localizes with F-actin filaments [13, 17] . Similarly, a GFPtagged version of the active PKD1 protein co-localized with Factin filaments at the leading edge ( Figures 2D-2F ). Furthermore, PAK4 localized to the leading edge of cells ( Figure 2G ), but a PAK4.S99A mutant was retained in the cytosol ( Figure 2H ). Interestingly, the localization of active PKD1 to the leading edge was linked to PAK4 phosphorylation at Ser 99 , since wildtype PAK4 co-localized with active PKD1 at the leading edge ( Figures 2I-2K ) and a PAK4.S99A mutant led to loss of PKD1 localization to the leading edge ( Figures 2L-2N ). This suggests that the translocation of both proteins to the leading edge is coupled to the PAK4 phosphorylation status at Ser 99 .
Ser 99 phosphorylation mediates binding of PAK4 to 14-3-3 proteins
Phosphorylation of proteins in the PKD substrate motif has been shown to generate a binding site for 14-3-3 proteins [17, [26] [27] [28] [29] . In PAK4, phosphorylation of Ser 99 within RSNpS 99 generates an ideal (RSXpS) 14-3-3-binding motif [30] (Figure 1B) .
Previously, a multiprotein complex consisting of PAK4, actin and 14-3-3 scaffolding proteins along with the PAK4 substrate LIMK was shown to regulate ADF (actin depolymerizing factor)/cofilin activity at the leading edge [4] . We therefore determined whether the formation of such a complex is dependent on active PKD1. To test this, we introduced PKD1.CA into cells, immunoprecipitated endogenous LIMK and probed samples for co-immunoprecipitated endogenous PAK4 and 14-3-3. We found that both proteins associated with LIMK in the presence of active PKD1 ( Figure 3A ). Since 14-3-3 scaffold proteins may function as the 'connectors' between signalling proteins of this complex, we next tested whether PAK4, when phosphorylated by PKD1, can bind to 14-3-3 proteins and whether this is dependent on Ser 99 phosphorylation. We found that active PKD1 induces the interaction of PAK4 with 14-3-3γ , and this is blocked when PAK4 is mutated at Ser 99 . These effects were obtained when PAK4 or PAK4.S99A were immunoprecipitated and samples were probed for co-immunoprecipitated 14-3-3γ ( Figure 3B ), but also vice versa when 14-3-3γ was immunoprecipitated and samples were probed for PAK4 or PAK4.S99A mutant ( Figure 3C ). Moreover, in the presence of active PKD1, both (A) In vitro kinase assays were performed with purified recombinant PKD1 and either purified GST-tagged PAK4 with only an inactivating K350M mutation (GST-PAK4.K350M) or additional mutation at Ser 474 (GST-PAK4.K350M.S474A) as substrates. To analyse substrate phosphorylation, Western blots of resolved proteins were probed with anti-pSer 474 -PAK4 and anti-pMOTIF (recognizes a phosphorylated PKD substrate motif) antibodies. Additional blots (α-PAK4 and α-PKD1) were performed to control equal input of purified proteins. The position of the 80 kDa band is indicated. (B) Analysis of group II PAKs (PAK4, PAK5 and PAK6) for PKD phosphorylation sites other than Ser 474 showed that Ser 99 in PAK4 and PAK5 lies within a PKD1 phosphorylation consensus motif. This motif is conserved through species and its phosphorylation generates a 14-3-3 consensus motif. B. taurus, Bos taurus; H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus. (C) In vitro kinase assays were performed with purified recombinant PKD1 and bacterially expressed GST-tagged kinase-dead PAK4 (GST-PAK4.K350M) additionally mutated by S99A or S474A, or both, as indicated. The top panel shows a radiolabelled kinase assay, and the other panels show non-radiolabelled kinase assays. Following the kinase reactions, samples were separated by SDS/PAGE and transferred on to nitrocellulose. PKD1-mediated phosphorylation of PAK4 was determined by autoradiography (top panel) or by probing with anti-pS474-PAK4 and anti-pMOTIF antibodies. Additional staining of nitrocellulose blots was performed (α-PAK4 and α-PKD1) to control equal input of purified proteins. The position of the 80 kDa band is indicated. (D) HeLa cells were co-transfected with vector control, FLAG-tagged PAK4.KM or PAK4.KM.S474A mutant and PKD1.CA or PKD1.KW, as indicated. Immediately after transfection, samples were treated with the PAK4 inhibitor PF-3758309 (400 nM) for 16 h. Cells were lysed and PAK4 was immunoprecipitated (IP) (α-FLAG). Samples were subjected to SDS/PAGE, transferred on to nitrocellulose and analysed by immunoblotting for PKD1-mediated phosphorylation of PAK4 (α-pMOTIF) and total PAK4 (α-FLAG). Additionally, lysates were analysed by Western blotting (WB) for PKD1 expression. Molecular masses are indicated in kDa. (E) HeLa cells were transfected with vector control, FLAG-tagged PAK4 or indicated PAK4 mutants. PAK4 was immunoprecipitated (IP) from cell lysates using anti-FLAG antibody. Samples were subjected to SDS/PAGE, transferred on to nitrocellulose and analysed by immunoblotting for PAK4 activation loop phosphorylation (with anti-pS474-PAK4) and total PAK4 (α-FLAG). The position of the 58 kDa band is indicated. (F) HeLa cells were co-transfected with vector control, FLAG-tagged PAK4 or PAK4.S99A mutant and vector control or PKD1.CA, as indicated. Immediately after transfection, samples were treated with the PAK4 inhibitor PF-3758309 (400 nM) for 16 h. Cells were lysed and PAK4 was immunoprecipitated (IP) (α-FLAG). Samples were subjected to SDS/PAGE, transferred on to nitrocellulose, and analysed by immunoblotting for PAK4 activation loop phosphorylation (with anti-pS474-PAK4) and total PAK4 (α-FLAG). Additionally, lysates were analysed by Western blotting (WB) for PKD1.CA expression. Molecular masses are indicated in kDa. PAK4 and 14-3-3γ co-localized at the leading edge, whereas when a PAK4.S99A mutant was combined with 14-3-3γ , both did not localize to the leading edge ( Figure 3D ). The effects observed were not 14-3-3 isoform-specific since similar results were obtained when 14-3-3ζ was expressed instead of the γ isoform (results not shown, and Supplementary Figure S3 at http://www.biochemj.org/bj/455/bj4550251add.htm). In order to test whether 14-3-3 binds directly to PAK4 phosphorylated at Ser 99 , we performed an in vitro kinase assay in which we phosphorylated wild-type PAK4 or the PAK4.S99A mutant with recombinant PKD1. We then performed a far-Western blot to detect binding of recombinant 14-3-3 protein. We found that 14-3-3 can directly bind to PAK4, when phosphorylated by PKD1 ( Figure 3E ). Recombinant 14-3-3 also bound to autophosphorylated PKD1, as shown previously by Hausser et al. [31] .
Ser 99 phosphorylation affects cell motility
At the leading edge, PAK4 has been shown to activate LIMK, but also to inactivate SSH1L [4] . The net effect of such signalling is an increase in (inactive) pSer 3 -cofilin and decreased directed cell migration [11] . Consequently, ectopic introduction of wild-type PAK4 decreased directed cell migration, whereas a PAK4.S99A mutant that does not localize to the leading edge did not significantly decrease directed cell migration when compared with the vector control ( Figure 4A ). The effects observed were not caused by differences in cell proliferation, since ectopic expression of neither wild-type PAK4 nor the PAK4.S99A mutant had an impact on cell proliferation in the period of analysis ( Figure 4B ). The calculated doubling of the cell index in the logarithmic growth phase were 5.2 + − 0.24 h for vector control, 4.84 + − 0.19 h for wildtype PAK4 and 4.97 + − 0.21 h for PAK4.S99A mutant. Taken together, these data suggest that blocking PAK4 localization to the leading edge can favour directed cell migration. The negative effects of wild-type PAK4 on directed cell migration are blocked when cells are treated with the PKD inhibitor CID755673 ( Figure 4C ). Inhibiting PKD1 led to a reversion of PAK4-mediated inhibitory effects on cell migration (compare PAK4-expressing cells in the absence and presence of CID755673). These results are also consistent with previous reports showing that introduction of active PKD1 into motile cells decreases directed cell migration by inhibiting cofilin-induced free actin barbed end formation [11, 17, 18] (Supplementary Figures S4 and S5 at http://www.biochemj.org/bj/455/bj4550251add.htm). Since both PKD isoforms PKD1 and PKD2 can phosphorylate PAK4 at Ser 99 , we next tested whether kinase-dead versions of these kinases can block PAK4-mediated decreases in cell migration. We found that both PKD1.KW and PKD2.KW mutants fully restored cell migration ( Figure 4D ), indicating that both kinases are redundant in their function towards PAK4.
Ser 99 phosphorylation affects PAK4 localization and downstream signalling at the leading edge
Since the PAK4.S99A mutant did not localize to the cell periphery ( Figure 3D ), we next analysed whether this affects downstream signalling towards cofilin at the leading edge. First, we determined F-actin structures in cells expressing wild-type PAK4 or PAK4.S99A. Cells expressing the S99A mutant showed a more motile phenotype as judged by organization of the F-actin structures ( Figure 5A ) and this correlated with our findings on directed cell migration ( Figure 4A ). However, when we quantified cofilin phosphorylation in cells expressing vector control, PAK4 or PAK4.S99A, we found only marginal differences between the two versions of PAK4 ( Figure 5B ). In control transfected cells 17.5 + − 5.7 % of the total cofilin was phosphorylated at Ser 3 . In cells expressing wild-type PAK4, cofilin phosphorylation was at 52.3 + − 2.2 %, and in cells expressing PAK4.S99A, we detected slightly decreased phospho-cofilin levels at 42.8 + − 3.2 %. This correlated with data on LIMK activity shown in Figure 4 (C), and indicates that the S99A mutated form of the kinase is functional. However, when we isolated the cytosolic and F-actin fractions, we found that, whereas PAK4 occurs in both fractions, PAK4.S99A is exclusively localized to the cytosol ( Figure 5C ). PAK4 was immunoprecipitated (IP) from cell lysates using an anti-FLAG antibody. Samples were subjected to SDS/PAGE, transferred on to nitrocellulose and analysed by immunoblotting for co-immunoprecipitated 14-3-3γ (α-HA). Samples were re-probed for total PAK4 (α-PAK4). Additionally, lysates were analysed by Western blotting for PKD1 expression (α-PKD1) and 14-3-3γ (α-HA) expression. (C) HEK-293T cells were co-transfected with FLAG-tagged PAK4 or PAK4.S99A mutant combined with vector or HA-tagged 14-3-3γ and PKD1.CA, as indicated. 14-3-3γ was immunoprecipitated (IP) from cell lysates using anti-HA antibody. Samples were subjected to SDS/PAGE, transferred on to nitrocellulose, and analysed by immunoblotting for co-immunoprecipitated PAK4 (α-FLAG). Samples were re-probed for total 14-3-3γ (α-HA). Additionally, lysates were analysed by Western blotting for PKD1 expression (α-FLAG) and PAK4 (α-FLAG) expression. (D) HeLa cells were co-transfected with FLAG-tagged PAK4 or PAK4.S99A mutant, HA-tagged 14-3-3γ and PKD1.CA, as indicated. Samples were subjected to immunofluorescence analysis in which PAK4 was detected by using anti-FLAG antibody and Alexa Fluor ® 647-conjugated secondary antibody, and 14-3-3γ was detected using an anti-HA antibody and Alexa Fluor ® 568-conjugated secondary antibody. Scale bars, 10 μm. (E) In vitro kinase (IVK) assays were performed with purified recombinant PKD1 and bacterially expressed GST-PAK4.KM or GST-PAK4.KM.S99A, as indicated. Following the kinase reactions, samples were separated by SDS/PAGE and transferred on to nitrocellulose. A far-Western blot was performed using recombinant His 6 -tagged 14-3-3ζ . 14-3-3 protein bound to PKD1 and PAK4 was determined by immunostaining with an anti-His antibody. Additional staining was performed to control equal input of purified PAK4 or PKD1 proteins.
Molecular masses are indicated in kDa in (A)-(C) and (E).
Moreover, localization of PAK4 or mutant correlated with cofilin phosphorylation. This indicates that the mechanism by which Ser 99 phosphorylation affects PAK4 function is that it regulates its function at the lamellipodium. Indeed, expression of wild-type PAK4 led to increased cofilin phosphorylation at the lamellipodia and cytosol ( Figure 5D , top row), whereas expression of a PAK4.S99A mutant that is not localized at the leading edge also led to cofilin phosphorylation but only in the cytosol ( Figure 5D , , A) , or E-plates (proliferation assays, B). After attachment of cells, cell migration or proliferation was continuously monitored in real-time using the xCELLigence RTCA DP instrument. Results are means + − S.D. for four experiments. Protein expression was controlled by Western blot (α-FLAG for PAK4 expression, α-β-actin for loading control). (C and D) HeLa cells were transfected with control vector, wild-type PAK4 or PAK4.S99A mutant, and treated with either DMSO (control) or the PKD inhibitor CID755673 (20 μM, during time of the assay) as indicated (C), or were additionally transfected with PKD1.KW or PKD2.KW as indicated (D). Transwell assays were performed to assess cell migration towards NIH 3T3-conditioned medium at 16 h. In (C), protein expression was controlled by Western blot (α-FLAG for PAK4 expression, α-β-actin for loading control). Additionally, samples were analysed by Western blot for expression and activity of LIMK (α-LIMK, α-pT508-LIMK). In (D), protein expression was controlled by Western blot for PAK4 (α-FLAG), PKD1 (α-PKD1), PKD2 (α-PKD2) or β-actin (for loading control). *P < 0.05 compared with vector control (first bar); **P < 0.05 compared with wild-type PAK4 (second bar). Molecular masses are indicated in kDa.
bottom row). This was confirmed further by performing barbed end formation [G-actin (globular actin) incorporation] assays, in which we show that PAK4 completely blocks barbed end formation, whereas cells expressing PAK4.S99A can still form barbed ends and show G-actin incorporation ( Figure 5E ). Taken together, this indicates that the ability of PAK4 to induce cofilin phosphorylation at Ser 3 is not affected by its mutation at Ser 99 , but that alone the lack of localization to the leading edge may be responsible for its effects on directed cell migration. In summary, with Ser 99 , we describe a novel PKD1 phosphorylation site in PAK4 that regulates PAK4 localization and complex formation with LIMK and 14-3-3 proteins. We suggest that lack of phosphorylation of PAK4 at Ser 99 prevents inactivation of cofilin at the leading edge, thus affecting directed cell migration ( Figure 6 ). 
DISCUSSION
The group II PAKs are effectors of RhoGTPases and play essential roles in regulating cell motility [1, 2] . Similarly, PKD isoforms are regulated by RhoGTPases [17, [32] [33] [34] . We have shown previously that PKD1, downstream of RhoA, can phosphorylate PAK4 directly at Ser 474 in its activation loop, increasing its activity towards its substrate LIMK [11] . Functional consequences of such signalling are an increase in the phospho-cofilin pool and decreased actin reorganization at the leading edge and directed cell migration [11] . In the present study, with Ser 99 , we have identified an additional PKD1 phosphorylation site in PAK4 that contributes to directed cell migration.
After blocking Ser 99 phosphorylation with a mutational approach (serine to alanine mutation), we found that the presence of Ser 99 phosphorylation had a slight, but reproducible, effect on PKD1-mediated activation loop phosphorylation at Ser 474 in vitro and in vivo ( Figures 1C and 1F ). But this was observed only when PAK4 autophosphorylation was inhibited either by using kinase-dead PAK4 mutants or PF-3758309 (PAK4 inhibitor). However, in cells with PAK4 autophosphorylation activity, phosphorylation at Ser 474 is probably independent of PKD1-mediated phosphorylation of Ser 99 ( Figure 1E ). Of the group II PAKs, only PAK4 and PAK5, but not PAK6, contain a PKD consensus motif surrounding Ser 99 ( Figure 1B ). As PAK4 and PAK5 are localized at the leading edge of migrating cells, and PAK6 is mainly localized to compartments in the nucleus [1, 3] (Supplementary Figure S2) , we tested whether Ser 99 phosphorylation is required to translocate PAK4 to the leading edge. We found loss of PAK4 at the leading edge when Ser 99 cannot be phosphorylated (Figure 2 ). This translated to altered cell migration. Overexpression of wild-type PAK4 decreased directed cell migration, whereas an S99A mutant that was not localized at the leading edge showed migration behaviour similar to wild-type cells ( Figures 4A, 4C and 4D) .
Actin reorganization at the leading edge, a key process in directed cell migration, is facilitated by the cofilin cycle [35] . PKD1 can regulate activities of both LIMK and SSH1L, thereby being a key regulator of cofilin activity [11, 17, 18, 36] . Activation of LIMK by PAK4 mediates phosphorylation and inactivation of cofilin [4] [5] [6] [7] . Although showing significant differences in their effects on cell migration, the expression of PAK4.S99A, similarly to that described for wild-type PAK4, increased cofilin phosphorylation ( Figure 5B ). This is not surprising since Ser 99 is located neither in the p21-Rho-binding domain (amino acids 10-66), nor in the protein kinase domain (amino acids 322-572), suggesting that binding to RhoGTPases can still occur and that the kinase activity is intact. However, we found that both PAK4 and PAK4.S99A localized in the cytosol, but that only wild-type PAK4 localized to the F-actin fraction ( Figure 5C ). In addition, we found that cofilin in PAK4.S99A-expressing cells is mainly phosphorylated in the cytosol and that in wild-type PAK4-expressing cells, phosphorylation occurs in the cytosol and the F-actin fraction. Consequently, expression of wild-type PAK4 led to increased cofilin phosphorylation at the lamellipodia and cytosol, whereas expression of a PAK4.S99A mutant that is not localized at the leading edge also led to cofilin phosphorylation, but only in the cytosol ( Figure 5D ). To demonstrate decreased cofilin activity when cells express PAK4, we performed Gactin incorporation (barbed end) assays. Cofilin-initiated G-actin incorporation at the cell periphery was blocked when cells were expressing wild-type PAK4, but not when PAK4.S99A was expressed ( Figure 5E ). This indicates that the ability of PAK4 to induce cofilin phosphorylation at Ser 3 is not affected by its mutation at Ser 99 , but that alone the lack of localization to the leading edge may be responsible for its effects on directed cell migration.
Phosphorylation of the PKD substrate motifs can generate a 14-3-3 protein consensus motif ( Figure 1B ). For example, PKD1-mediated phosphorylation of SSH1L at Ser 978 has been shown to lead to binding of 14-3-3 [17] . Similarly, PKD1 phosphorylation of PAK4 at Ser 99 created a 14-3-3-binding motif ( Figures 3B  and 3C ) and mediated direct binding of 14-3-3 in far-Western blot assays ( Figure 3E ). Although both PKD1-phosphorylated PAK4 and PKD1 bind 14-3-3 directly, this does not prove the formation of a complex between these three proteins. It was shown previously that PAK4 at the leading edge, along with LIMK, interacts with SSH1L and 14-3-3 to form a multiprotein complex which regulates the activity of cofilin [4] . We found that PKD1 may contribute to such complex formation, since both PAK4 and 14-3-3 associated with LIMK in the presence of active PKD1 ( Figure 3A) . The mechanisms by which such a complex is formed are not yet fully elucidated. One possibility of how 14-3-3 proteins could contribute to complex formation is due to their ability to form dimers or multimers [37] . Moreover, the binding of 14-3-3 proteins to PKD1, as well as to LIMK1-phosphorylated cofilin, has been described previously [31, 38] , suggesting that 14-3-3 may function as scaffold to keep this complex at the leading edge. However, our data do not exclude additional levels of regulation of the PAK4-SSH1L-LIMK complex through 14-3-3 proteins or other scaffolding proteins.
To conclude, in the present study, we identified an additional mechanism by which PAK4 function and directed cell migration can be regulated. We describe PKD1-mediated phosphorylation of Ser 99 as a requirement for complex formation of PAK4 with 14-3-3 proteins, a mechanism that targets a PAK4-LIMK complex to the leading edge and facilitates cofilin phosphorylation at this location ( Figure 6 ). In vitro kinase assays were performed with purified recombinant PKD2 or PKD3 and either purified GST-tagged PAK4 with only an inactivating K350M mutation (GST-PAK4.K350M), additional mutation at Ser 99 (GST-PAK4.K350M.S99A) or additional mutation at Ser 99 and S474 (GST-PAK4.K350M.S99A.S474A). To analyse substrate phosphorylation, Western blots of resolved proteins were probed with anti-pMOTIF antibody (recognizes a phosphorylated PKD substrate motif). Additional blots (α-PAK4 and α-PKD2 or α-PKD3) were performed to control input of purified proteins. The position of the 80 kDa band is indicated. 
